Literature DB >> 7725752

Parathyroid localization by catheterization of large cervical and mediastinal veins to determine serum concentrations of intact parathyroid hormone.

B E Nilsson1, L E Tisell, S Jansson, B F Zackrisson, G Lindstedt, P A Lundberg.   

Abstract

A success rate of about 90% has been achieved after primary operations for hyperparathyroidism, compared with 60% to 80% in most series of secondary operations. The present reoperative series involved 29 patients who underwent venous catheterization with blood sampling for the determination of intact parathyroid hormone before undergoing repeat parathyroid surgery. Blood samples were taken from the internal jugular veins, innominate veins, and superior caval vein. No attempt was made to perform superselective catheterization of the small neck and mediastinal veins. The reoperations were done by four surgeons who did 1, 2, 13, and 13 of the reoperations, respectively. In all patients, distinct step-ups in parathyroid hormone concentrations were found. On average, the gradient between the highest and lowest value was about 5. Close to the location of the step-ups, diseased parathyroid tissue was found in 27 of the patients. In two cases no parathyroid tissue was found, and these patients remained hyperparathyroid postoperatively. They had been treated by the surgeon who did only two of the operations. When the step-up was observed in the left innominate vein, we could not differentiate mediastinal from low cervical adenomas. No patient developed hypoparathyroidism. To avoid this complication, autotransplantation of diseased parathyroid tissue into the abdominal subcutaneous fat was done in nine patients. No case of recurrent laryngeal nerve paralysis occurred. The introduction of reliable assays for the analysis of parathyroid hormone can make selective catheterization unnecessary when localizing remaining parathyroid glands in patients with persistent hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7725752     DOI: 10.1007/bf00353777

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  23 in total

1.  Management of patients with persistent or recurrent primary hyperparathyroidism.

Authors:  S E Carty; J A Norton
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

2.  Recommended methods for the determination of four enzymes in blood.

Authors: 
Journal:  Scand J Clin Lab Invest       Date:  1974-06       Impact factor: 1.713

3.  [Direct estimation of creatinine in serum and in urine without deproteinization using a modified Jaffé method].

Authors:  R Helger; H Rindfrey; J Hilgenfeldt
Journal:  Z Klin Chem Klin Biochem       Date:  1974-07

4.  Localization of parathyroid adenomas by selective venous catheterization and radioimmunoassay.

Authors:  R E Reitz; J J Pollard; C A Wang; D J Fleischli; O Cope; T M Murray; L J Deftos; J T Potts
Journal:  N Engl J Med       Date:  1969-08-14       Impact factor: 91.245

5.  Clinical management of persistent and/or recurrent primary hyperparathyroidism.

Authors:  C S Grant; J A van Heerden; J W Charboneau; E M James; C C Reading
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

6.  Localizing studies in patients with persistent or recurrent hyperparathyroidism.

Authors:  K E Levin; G A Gooding; M Okerlund; C B Higgins; D Norman; T H Newton; Q Y Duh; C D Arnaud; A E Siperstein; Q H Zeng
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

7.  Localization procedures in patients requiring reoperation for hyperparathyroidism.

Authors:  O H Clark; D D Stark; G A Gooding; A A Moss; S B Arnaud; T H Newton; D Norman; W O Bank; C D Arnaud
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

8.  Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

Authors:  S R Nussbaum; R J Zahradnik; J R Lavigne; G L Brennan; K Nozawa-Ung; L Y Kim; H T Keutmann; C A Wang; J T Potts; G V Segre
Journal:  Clin Chem       Date:  1987-08       Impact factor: 8.327

9.  Studies in patients with hyperparathyroidism using a new two-site immunochemiluminometric assay for circulating intact (1-84) parathyroid hormone.

Authors:  I R Curley; M H Wheeler; J P Aston; R C Brown; I Weeks; J S Woodhead
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

10.  Reoperative parathyroid surgery for persistent hyperparathyroidism.

Authors:  M F Brennan; J L Doppman; S J Marx; A M Spiegel; E M Brown; G D Aurbach
Journal:  Surgery       Date:  1978-06       Impact factor: 3.982

View more
  3 in total

1.  Super-selective venous sampling in conjunction with quickPTH for patients with persistent primary hyperparathyroidism: report of five cases.

Authors:  Oliver Gimm; Lars-Gunnar Arnesson; Pia Olofsson; Olallo Morales; Claes Juhlin
Journal:  Surg Today       Date:  2012-01-26       Impact factor: 2.549

2.  Selective venous sampling in recurrent and persistent hyperparathyroidism: indication, technique, and results.

Authors:  Philippe C J Chaffanjon; David Voirin; Ashok Vasdev; Olivier Chabre; Norman M Kenyon; Pierre Yves Brichon
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

3.  Bilateral internal jugular venous sampling for parathyroid hormone determination in patients with nonlocalizing primary hyperparathyroidism.

Authors:  Raul Alvarado; Goswin Meyer-Rochow; Mark Sywak; Leigh Delbridge; Stan Sidhu
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.